Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

LATS2

RBC: LATS2 · Substrate: SGKtide · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Capivasertib96.20.64
Netarsudil92.30.68
Midostaurin90.90.50
Ponatinib78.90.53
Defactinib74.80.45
Sunitinib71.00.52
Gilteritinib65.80.51
Pacritinib62.90.45
Baricitinib58.90.62
Fostamatinib56.40.61
Neratinib40.60.60
Brigatinib39.50.51
Vemurafenib38.90.60
Darovasertib37.50.72
Ruxolitinib35.20.59

Known variants

No variants catalogued.
Open in new tab